JAMA Dermat:微针加速光动力疗法对光化性角化病的治疗

2017-05-18 zhangfan MedSci原创

20分钟氨基乙酰丙酸和微针预处理可有效提高传统光动力学疗法的效率,提高病变清除率并且过程几乎无痛

光动力疗法(PDT)是一种有效的光化性角化病(AKs)治疗方式,然而较长治疗时间和疼痛阻碍了PDT作为标准AK治疗方案的应用。近日研究人员评估了微针加速光动力疗法在疗效与减轻疼痛方面的效果。

这项MNPDT-II的研究,招募了33名面部光化性角化病患者,从2015年至2016年进行,共32人完成研究。参与者随机分入2组,先进行10分钟或20分钟的氨基乙酰丙酸处理,再用微针滚轮(200 um)或假滚轮预处理后,患者进行蓝光(Blu-U,DUSA制药)1000秒,总剂量10 J/cm的治疗。研究的主要终点是定量测量的疾病缓解,次要终点是评估微针预处理相关的疼痛。

对于完成研究的32人开展随访,20分钟组平均34.5天,10分钟组平均30.2天。对于20分钟预处理组,平均微针预处理的AK清除率为76%,对照组为58%,其中3名微针处理患者实现完全清除,但二者差距不显著(P=0.25)。蓝光照射下视觉模拟评分(VAS)的疼痛评估微针组疼痛减轻但与对照组差距不显著(0.7 以及0.4; P=0.28)。10分钟的潜伏期微针预处理后AK清除率为43%,对照组为38%(P=0.66) ,二组的疼痛评分无显著差异。

研究认为20分钟氨基乙酰丙酸和微针预处理可有效提高传统光动力学疗法的效率,可将预处理时间从1小时减少到20分钟,提高病变清除率并且过程几乎无痛。

原始出处:


本文系梅斯医学(MedSci)原创编译整理,转载需授权!

版权声明:
本网站所有内容来源注明为“梅斯医学”或“MedSci原创”的文字、图片和音视频资料,版权均属于梅斯医学所有。非经授权,任何媒体、网站或个人不得转载,授权转载时须注明来源为“梅斯医学”。其它来源的文章系转载文章,或“梅斯号”自媒体发布的文章,仅系出于传递更多信息之目的,本站仅负责审核内容合规,其内容不代表本站立场,本站不负责内容的准确性和版权。如果存在侵权、或不希望被转载的媒体或个人可与我们联系,我们将立即进行删除处理。
在此留言
评论区 (5)
#插入话题
  1. [GetPortalCommentsPageByObjectIdResponse(id=1648837, encodeId=f1dc164883ee5, content=<a href='/topic/show?id=d7a328e40fd' target=_blank style='color:#2F92EE;'>#光化性角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28740, encryptionId=d7a328e40fd, topicName=光化性角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a8a23689373, createdName=jinweidong, createdTime=Mon Jan 15 23:35:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=205358, encodeId=e3862053580b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEKfBrU0HZuah3ib094aw9I85jP8DgFf6sS7X1IogUlOPUuMZxPBmqvEFjicg15pIDdvXzRXvrBSy1yQ/0, createdBy=d6712028210, createdName=柳叶刀888, createdTime=Thu Jun 01 22:28:20 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546288, encodeId=0e3615462884c, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623585, encodeId=8f5b16235856d, content=<a href='/topic/show?id=a323909163b' target=_blank style='color:#2F92EE;'>#角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90916, encryptionId=a323909163b, topicName=角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10a720562694, createdName=guihongzh, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200016, encodeId=6ad120001605, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29c1659033, createdName=1dde4e6am60(暂无匿称), createdTime=Fri May 19 14:47:37 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
  2. [GetPortalCommentsPageByObjectIdResponse(id=1648837, encodeId=f1dc164883ee5, content=<a href='/topic/show?id=d7a328e40fd' target=_blank style='color:#2F92EE;'>#光化性角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28740, encryptionId=d7a328e40fd, topicName=光化性角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a8a23689373, createdName=jinweidong, createdTime=Mon Jan 15 23:35:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=205358, encodeId=e3862053580b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEKfBrU0HZuah3ib094aw9I85jP8DgFf6sS7X1IogUlOPUuMZxPBmqvEFjicg15pIDdvXzRXvrBSy1yQ/0, createdBy=d6712028210, createdName=柳叶刀888, createdTime=Thu Jun 01 22:28:20 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546288, encodeId=0e3615462884c, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623585, encodeId=8f5b16235856d, content=<a href='/topic/show?id=a323909163b' target=_blank style='color:#2F92EE;'>#角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90916, encryptionId=a323909163b, topicName=角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10a720562694, createdName=guihongzh, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200016, encodeId=6ad120001605, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29c1659033, createdName=1dde4e6am60(暂无匿称), createdTime=Fri May 19 14:47:37 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
    2017-06-01 柳叶刀888

    学习了

    0

  3. [GetPortalCommentsPageByObjectIdResponse(id=1648837, encodeId=f1dc164883ee5, content=<a href='/topic/show?id=d7a328e40fd' target=_blank style='color:#2F92EE;'>#光化性角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28740, encryptionId=d7a328e40fd, topicName=光化性角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a8a23689373, createdName=jinweidong, createdTime=Mon Jan 15 23:35:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=205358, encodeId=e3862053580b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEKfBrU0HZuah3ib094aw9I85jP8DgFf6sS7X1IogUlOPUuMZxPBmqvEFjicg15pIDdvXzRXvrBSy1yQ/0, createdBy=d6712028210, createdName=柳叶刀888, createdTime=Thu Jun 01 22:28:20 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546288, encodeId=0e3615462884c, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623585, encodeId=8f5b16235856d, content=<a href='/topic/show?id=a323909163b' target=_blank style='color:#2F92EE;'>#角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90916, encryptionId=a323909163b, topicName=角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10a720562694, createdName=guihongzh, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200016, encodeId=6ad120001605, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29c1659033, createdName=1dde4e6am60(暂无匿称), createdTime=Fri May 19 14:47:37 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
  4. [GetPortalCommentsPageByObjectIdResponse(id=1648837, encodeId=f1dc164883ee5, content=<a href='/topic/show?id=d7a328e40fd' target=_blank style='color:#2F92EE;'>#光化性角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28740, encryptionId=d7a328e40fd, topicName=光化性角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a8a23689373, createdName=jinweidong, createdTime=Mon Jan 15 23:35:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=205358, encodeId=e3862053580b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEKfBrU0HZuah3ib094aw9I85jP8DgFf6sS7X1IogUlOPUuMZxPBmqvEFjicg15pIDdvXzRXvrBSy1yQ/0, createdBy=d6712028210, createdName=柳叶刀888, createdTime=Thu Jun 01 22:28:20 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546288, encodeId=0e3615462884c, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623585, encodeId=8f5b16235856d, content=<a href='/topic/show?id=a323909163b' target=_blank style='color:#2F92EE;'>#角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90916, encryptionId=a323909163b, topicName=角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10a720562694, createdName=guihongzh, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200016, encodeId=6ad120001605, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29c1659033, createdName=1dde4e6am60(暂无匿称), createdTime=Fri May 19 14:47:37 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
  5. [GetPortalCommentsPageByObjectIdResponse(id=1648837, encodeId=f1dc164883ee5, content=<a href='/topic/show?id=d7a328e40fd' target=_blank style='color:#2F92EE;'>#光化性角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=43, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28740, encryptionId=d7a328e40fd, topicName=光化性角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=6a8a23689373, createdName=jinweidong, createdTime=Mon Jan 15 23:35:00 CST 2018, time=2018-01-15, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=205358, encodeId=e3862053580b, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=71, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://wx.qlogo.cn/mmopen/PiajxSqBRaEKfBrU0HZuah3ib094aw9I85jP8DgFf6sS7X1IogUlOPUuMZxPBmqvEFjicg15pIDdvXzRXvrBSy1yQ/0, createdBy=d6712028210, createdName=柳叶刀888, createdTime=Thu Jun 01 22:28:20 CST 2017, time=2017-06-01, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1546288, encodeId=0e3615462884c, content=<a href='/topic/show?id=0da528e33ce' target=_blank style='color:#2F92EE;'>#光动力#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=44, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=28733, encryptionId=0da528e33ce, topicName=光动力)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=2b6213920685, createdName=luckyshitiancai_42705688, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1623585, encodeId=8f5b16235856d, content=<a href='/topic/show?id=a323909163b' target=_blank style='color:#2F92EE;'>#角化病#</a>, beContent=null, objectType=article, channel=null, level=null, likeNumber=42, replyNumber=0, topicName=null, topicId=null, topicList=[TopicDto(id=90916, encryptionId=a323909163b, topicName=角化病)], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=10a720562694, createdName=guihongzh, createdTime=Sat May 20 07:35:00 CST 2017, time=2017-05-20, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=200016, encodeId=6ad120001605, content=学习了, beContent=null, objectType=article, channel=null, level=null, likeNumber=83, replyNumber=0, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=a29c1659033, createdName=1dde4e6am60(暂无匿称), createdTime=Fri May 19 14:47:37 CST 2017, time=2017-05-19, status=1, ipAttribution=)]
    2017-05-19 1dde4e6am60(暂无匿称)

    学习了

    0

相关资讯

NEJM:口服烟酰胺(VB3)可降低皮肤癌风险

非黑色素瘤皮肤癌如基底细胞癌、鳞状细胞癌,通常是由紫外线(UV)辐射导致的。而有研究表明烟酰胺(VB3)可以对UV造成的损伤产生拮抗保护作用,并且减少新的光化性角化病(癌前病变)。 研究者进行了一项双盲、随机、对照的3期试验,研究对象需满足以下条件:纳入研究前5年至少2种非黑色素瘤皮肤癌。研究者按1:1比例将386名研究对象分为2组,一组服用烟酰胺500mg ,每日两次;另一组则服用安慰剂,服药时